Shaida Khan, D.O.

Medical Director of Neurology, Parkland Hospital

  • Neurology
  • Autoimmune Neurology
  • Amyotrophic Lateral Sclerosis (ALS)

Biography

Shaida Khan, D.O., is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center. She specializes in evaluating, diagnosing, and treating autoimmune peripheral neurological disorders and neuromuscular disorders such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), peripheral neuropathy, inflammatory myopathies, muscular dystrophy, and amyotrophic lateral sclerosis (ALS).

Dr. Khan earned her medical degree at the University of North Texas Health Science Center. She completed her neurology residency at UT Southwestern Medical Center, where she also gained advanced training through a fellowship in neuromuscular medicine.

Certified by the American Board of Psychiatry and Neurology in neuromuscular medicine and neurology, she joined the UT Southwestern faculty in 2017.

Dr. Khan is the Medical Director of the Neurology Clinic at Parkland Memorial Hospital. She is a member of several hospital committees, including the Professional Staff Peer Review Oversight Committee and the Pharmacy and Therapeutics/Drug Utilization Review Committee. She also serves as a mentor for numerous quality improvement projects.

In the UTSW Department of Neurology, Dr. Khan serves on the Academic Awards and Recognition Committee, the Clinical Competency Committee for the Neurology Residency Program, and the Women’s Issues in Medicine Committee.

Dr. Khan’s research interests include myasthenia gravis and muscular dystrophy. She is the site investigator for several clinic trials for promising myasthenia gravis therapies. She was awarded a three-year grant from the Fichtenbaum Charitable Trust to improve the quality of care, education, and research in the myasthenia gravis population of Dallas County, and in 2021 she established the Myasthenia Gravis Clinic at Parkland.

She is a member of several professional societies and serves as Vice Chair of the American Academy of Neurology’s Women’s Issues in Neurology Section.

Dr. Khan has received numerous awards for her work as a clinician, educator, and investigator, including a training grant from the NIH for her investigations in Duchenne muscular dystrophy–associated cardiomyopathy and, for two consecutive years, UT Southwestern’s Trephined Cranium Teaching Award in recognition of outstanding teaching to the neurology resident trainees. In addition, she was elected by the medical students of UT Southwestern to the Alpha Omega Alpha Honor Medical Society.

Education & Training
  • Fellowship - UT Southwestern Medical Center (2016-2018), Neuromuscular Disease
  • Residency - UT Southwestern Medical Center (2012-2016), Neurology
  • Medical School - UNT Health Science Center at Fort Worth (2008-2012)
Professional Associations & Affiliations
  • American Academy of Neurology
  • American Osteopathic Association
  • Dallas County Medical Society
  • Texas Neurological Society
Honors & Awards
  • PACT Blue Pin Recipient 2021, UT Southwestern
  • Trephined Cranium Award 2020-2021, UT Southwestern
  • Fred Baskin Young Investigator Award 2017, UT Southwestern
  • Best Fellow Poster 2017, Research Appreciation Day, UT Southwestern
  • Awardee 2016-2018, UT Southwestern Wellstone MDCRC Training Grant¬–NIH 1U54HD08735-01
  • AAN Fellow Scholarship 2017, American Academy of Neurology Annual Meeting
  • Roger Rosenberg Fellow of the Year Award 2016-2017, UT Southwestern
  • Neurology Resident Teaching Award 2013, UT Southwestern
  • Alpha Omega Alpha Honor Medical Society 2012, UT Southwestern
Books & Publications
  • Books
    • A 59-Year-Old Woman with Subacute Lower Limb Weakness and Painful Paresthesia in A Case-Based Guide to Neuromuscular Pathology
      Khan S, Cai C (2020), Springer Nature Switzerland AG
  • Publications
    • Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy.
      Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PPA, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V, Orphanet journal of rare diseases 2022 Jan 17 1 23
    • Rapidly Progressive Paraneoplastic Neuropathy Associated with Renal Cell Carcinoma: A Case Report.
      Shah D, Trivedi J, Vernino S, Khan S, Journal of cancer science and clinical therapeutics 2022 6 3 333-335
    • Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia.
      Shaibani A, Khan S, Shinawi M, Neurology. Genetics 2021 Aug 7 4 e612
    • Brody Myopathy Presenting as Recurrent Rhabdomyolysis.
      Bergstrom C, Remz M, Khan S, McNutt M, The American journal of medicine 2021 Jul 134 7 e429-e430
    • New patient access via telehealth in neuromuscular medicine during COVID-19.
      Khan S, Kramer A, McIver J, Cady L, Trivedi JR, Work (Reading, Mass.) 2021 Jun
    • Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
      Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M, JAMA neurology 2020 Feb
    • Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
      Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, ShankaracharyaSmith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L, Moreno CAM, Kamalakaran S, Goldstein DB, Gitler AD, Harris T, Myers RM, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE Neuron 2018 Mar 97 6 1268-1283.e6
    • Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
      Cheeran D, Khan S, Khera R, Bhatt A, Garg S, Grodin JL, Morlend R, Araj FG, Amin AA, Thibodeau JT, Das S, Drazner MH, Mammen PPA Journal of the American Heart Association 2017 Oct 6 10
    • Cardiac Atrophy: a Novel Mechanism for Duchenne Muscular Dystrophy (DMD)-Associated Cardiomyopathy
      Shaida Khan, Daniel Cheeran, Sonia Garg, Justin Grodin, Robert Morlend, Faris Araj, Alpesh Amin, Jennifer Thibodeau, Mark Drazner and Pradeep Mammen Journal of the American College of Cardiology 2017 69 11
    • Bilateral Asymmetrical Asterixis as Limb-shaking Transient Ischemic Attack in Bilateral Carotid Stenosis.
      Khan S, Chang E, Saniuk G, Shang T Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015 Jan 24 1 e29-30
Research
  • Muscular dystrophy
  • Myasthenia gravis
  • Quality improvement

Clinical Focus

  • Autoimmune Neurology
  • Amyotrophic Lateral Sclerosis (ALS)
  • Autoimmune peripheral neurological disorders
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Inflammatory myopathies
  • Muscular dystrophy
  • Myasthenia gravis
  • Neuromuscular Disorders
  • Peripheral Neuropathy

See More